1. Home
  2. NSPR vs NTIC Comparison

NSPR vs NTIC Comparison

Compare NSPR & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • NTIC
  • Stock Information
  • Founded
  • NSPR 2005
  • NTIC 1970
  • Country
  • NSPR United States
  • NTIC United States
  • Employees
  • NSPR N/A
  • NTIC N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • NTIC Industrial Specialties
  • Sector
  • NSPR Health Care
  • NTIC Industrials
  • Exchange
  • NSPR Nasdaq
  • NTIC Nasdaq
  • Market Cap
  • NSPR 75.1M
  • NTIC 71.5M
  • IPO Year
  • NSPR N/A
  • NTIC N/A
  • Fundamental
  • Price
  • NSPR $2.44
  • NTIC $8.90
  • Analyst Decision
  • NSPR Strong Buy
  • NTIC Buy
  • Analyst Count
  • NSPR 2
  • NTIC 1
  • Target Price
  • NSPR $4.50
  • NTIC $20.00
  • AVG Volume (30 Days)
  • NSPR 386.2K
  • NTIC 85.0K
  • Earning Date
  • NSPR 08-05-2025
  • NTIC 07-10-2025
  • Dividend Yield
  • NSPR N/A
  • NTIC 3.16%
  • EPS Growth
  • NSPR N/A
  • NTIC N/A
  • EPS
  • NSPR N/A
  • NTIC 0.31
  • Revenue
  • NSPR $7,027,000.00
  • NTIC $85,268,129.00
  • Revenue This Year
  • NSPR $4.85
  • NTIC $2.05
  • Revenue Next Year
  • NSPR $113.47
  • NTIC $4.70
  • P/E Ratio
  • NSPR N/A
  • NTIC $28.09
  • Revenue Growth
  • NSPR 8.49
  • NTIC 3.46
  • 52 Week Low
  • NSPR $1.99
  • NTIC $6.75
  • 52 Week High
  • NSPR $3.80
  • NTIC $15.09
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 54.16
  • NTIC 64.64
  • Support Level
  • NSPR $2.12
  • NTIC $7.91
  • Resistance Level
  • NSPR $2.46
  • NTIC $8.97
  • Average True Range (ATR)
  • NSPR 0.16
  • NTIC 0.52
  • MACD
  • NSPR 0.01
  • NTIC 0.10
  • Stochastic Oscillator
  • NSPR 73.33
  • NTIC 87.95

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.

Share on Social Networks: